SCHEMBL1865174

SCHEMBL1865174

C=C(CCC(=O)OCc1ccccc1)CCC(=O)OCc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.61
MAPK1 P28482 2/20 0.61
L3MBTL1 Q9Y468 2/20 0.61
TDP1 Q9NUW8 3/20 0.52
KMT2A Q03164 2/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A3 Q01959 1/20 0.52
LMNA P02545 4/20 0.50
NOTUM Q6P988 1/20 0.50
MEN1 O00255 1/20 0.50
POLB P06746 1/20 0.50
MAPT P10636 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.47
HCAR2 Q8TDS4 1/20 0.47
CA12 O43570 1/20 0.47
CA1 P00915 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
CDC25B P30305 1/20 0.46
HTT P42858 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1177836 0.90 ALDH1A1 (0.73) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL21861568 0.89 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL31634981 0.86 ALDH1A1 (0.58) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL13451270 0.86 ALDH1A1 (0.59) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL7632247 0.85 ALDH1A1 (0.61) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
Succinic Acid Monobenzyl Ester SCHEMBL827012 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
Succinic Acid SCHEMBL28290797 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL1856208 0.85 ALDH1A1 (0.66) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL6381740 0.84 ALDH1A1 (0.56) ALDH1A1MAPK1L3MBTL1TDP1KMT2A
SCHEMBL27494446 0.83 ALDH1A1 (0.63) ALDH1A1MAPK1L3MBTL1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943751-B2 Ladder copolymers NEW YORK UNIVERSITY (US) 2011-05-17 US disclosed
US-20090137738-A1 LADDER COPOLYMERS NEW YORK UNIVERSITY (US) 2009-05-28 US disclosed
US-7479548-B1 Nucleic acid based ladder copolymers NEW YORK UNIVERSITY (US) 2009-01-20 US disclosed
US-20090005329-A1 NUCLEIC ACID BASED LADDER COPOLYMERS NEW YORK UNIVERSITY (US) 2009-01-01 US disclosed
EP-1639078-A2 LADDER COPOLYMERS New York University (US) 2006-03-29 EP disclosed
WO-2005001035-A2 LADDER COPOLYMERS NEW YORK UNIVERSITY (US) 2005-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090005329-A1 NUCLEIC ACID BASED LADDER COPOLYMERS POLL, POLM, POLRMT ALDH1A1 2760/4885MAPK1 1047/4885L3MBTL1 49/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.